The death receptor CD95 activates the cofilin pathway to stimulate tumour cell invasionDifferentiated human colorectal cancer cells protect tumor-initiating cells from irinotecanComparative Proteomics of Colon Cancer Stem Cells and Differentiated Tumor Cells Identifies BIRC6 as a Potential Therapeutic Target
author
type
label
B.L. Emmink